Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 12,949,000 | 10,576,000 | 11,053,000 | 10,060,000 | 8,180,000 |
| Depreciation Amortization | 2,832,000 | 2,777,000 | 2,177,000 | 2,093,000 | 2,124,000 |
| Income taxes - deferred | 22,000 | -1,762,000 | -1,168,000 | -235,000 | -676,000 |
| Accounts receivable | -650,000 | -394,000 | -713,000 | -599,000 | -108,000 |
| Other Working Capital | -1,639,000 | 1,248,000 | 968,000 | -1,021,000 | 936,000 |
| Other Operating Activity | 1,458,000 | 2,577,000 | 1,931,000 | 1,501,000 | 633,000 |
| Operating Cash Flow | $14,972,000 | $15,022,000 | $14,248,000 | $11,799,000 | $11,089,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,281,000 | -2,485,000 | -2,155,000 | -2,478,000 | -1,938,000 |
| Net Acquisitions | -1,214,000 | -1,388,000 | -18,023,000 | -987,000 | -580,000 |
| Purchase Of Investment | -3,668,000 | -9,659,000 | -467,000 | -5,660,000 | -11,617,000 |
| Sale Of Investment | 3,059,000 | 7,988,000 | 426,000 | 9,187,000 | 12,061,000 |
| Other Investing Activity | -83,000 | -368,000 | -72,000 | -341,000 | -273,000 |
| Investing Cash Flow | $-4,187,000 | $-5,912,000 | $-20,291,000 | $-279,000 | $-2,347,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 8,430,000 | 19,626,000 | 6,385,000 | 1,215,000 | 514,000 |
| Debt Issued | 1,638,000 | 5,100,000 | 6,000 | 6,000 | 17,000 |
| Debt Repayment | -24,000 | -18,000 | -13,000 | -196,000 | -395,000 |
| Common Stock Issued | 1,486,000 | 1,562,000 | 1,135,000 | 774,000 | 684,000 |
| Common Stock Repurchased | -6,651,000 | -5,607,000 | -6,722,000 | -1,717,000 | -1,384,000 |
| Dividend Paid | -5,024,000 | -4,670,000 | -4,267,000 | -3,793,000 | -3,251,000 |
| Other Financing Activity | -7,319,000 | -21,691,000 | -2,633,000 | -732,000 | -1,291,000 |
| Financing Cash Flow | $-7,464,000 | $-5,698,000 | $-6,109,000 | $-4,443,000 | $-5,106,000 |
| Exchange Rate Effect | -323,000 | 275,000 | 180,000 | -225,000 | 190,000 |
| Beginning Cash Position | 7,770,000 | 4,083,000 | 16,055,000 | 9,203,000 | 5,377,000 |
| End Cash Position | 10,768,000 | 7,770,000 | 4,083,000 | 16,055,000 | 9,203,000 |
| Net Cash Flow | $2,998,000 | $3,687,000 | $-11,972,000 | $6,852,000 | $3,826,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,972,000 | 15,022,000 | 14,248,000 | 11,799,000 | 11,089,000 |
| Capital Expenditure | -3,066,000 | -2,942,000 | -2,666,000 | -2,632,000 | -2,175,000 |
| Free Cash Flow | 11,906,000 | 12,080,000 | 11,582,000 | 9,167,000 | 8,914,000 |